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Abstract
Knowledge production and scientiﬁc research have become increasingly more collab-
orative and international, particularly in pharmaceuticals. We analyze international
research networks on the country level in diﬀerent disease groups. Our empirical
analysis is based on a unique dataset of scientiﬁc publications related to pharma-
ceutical research. Using social network analysis, we ﬁnd that both the number of
countries and their connectivity increase in almost all disease groups. The cores of
the networks consist of high income OECD countries and remain rather stable over
time. We use network regression techniques in order to analyze the dynamics of the
networks. Our results indicate that an accumulative advantage based on preferential
attachment and point connectivity as a proxy for multi-connectivity are positively
related to changes in the countries’ collaboration intensity.
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Collaboration between diﬀerent authors and institutions has become an increasingly more
important mode of knowledge generation in almost all scientiﬁc disciplines (Wuchty et al.,
2007). Particularly in industries with rapidly developing and widely distributed knowl-
edge bases, no single actor has the ability to keep pace with the scientiﬁc and techno-
logical progress in all areas. Consequently, increasing collaboration within collaboration
networks have been found to be a means by which actors can pool, exchange and de-
velop ideas, knowledge and other resources (Powell and Grodal, 2005, Powell et al., 1996,
Powell and Brantley, 1992).
Particularly in the pharmaceutical industry, innovation is based on scientiﬁc advances
and thus clearly connected to basic and applied research (Lim, 2004). Pharmaceutical
innovation can be seen as the result of interaction and collaboration between a broad set
of diﬀerent types of agents endowed with complementary knowledge, competencies and
other resources (e.g. Pisano, 1991, Orsenigo, 1989). Since the industry is characterized
by a complex, expanding and dispersed knowledge base, the locus of innovation, and thus
the appropriate level of analysis, is no longer the individual actor, but rather the entire
network (Powell et al., 1996). The structure of the network and the agents’ positions
within it determine the agents’ access to the relevant sources of knowledge and therefore
their innovative activities and performance (Kogut et al., 1992).
Based on the literature that shows an increasing importance of network structures and the
increasing amount of cross-country research collaboration in pharmaceuticals, we explore
diﬀerences in collaboration patterns at the country level in diﬀerent areas of pharma-
ceutical research and their developments over time. We use social network analysis to
visualize collaboration networks and to calculate network statistics for diﬀerent disease
groups. Moreover, we analyze endogenous network dynamics, i.e. mechanisms within the
network that are responsible for new connections being build up or existing ones being cut
oﬀ. More precisely, we analyze whether homophily, i.e. similarity of countries, preferen-
tial attachment, i.e. the connectedness of countries, or multi-connectivity are the driving
factors of tie formation within the networks.
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dyadic data (Butts and Carley, 2001, Krackhardt, 1988). More precisely, we use the mul-
tiple regression quadratic assignment procedure (MRQAP) with double semi-partialing
(DSP) as proposed by Dekker et al. (2007), which is particularly robust against multi-
collinearity and network-autocorrelation.
Our empirical analysis is performed on a unique dataset of publications in scientiﬁc jour-
nals related to pharmaceutical research. We analyze three periods, 1998 to 2000, 2002
to 2004, and 2006 to 2008. Visual inspection reveals that high income OECD countries
are located in the center of the network in all periods and disease areas. Although often
connected to countries in the core, only a few non-OECD countries have managed to be-
come part of the center of the international research community. Our descriptive network
statistics indicate increasing cross-county collaboration in almost all disease groups.
Our regression results reveal that tie formation and break-up is positively related to the
amount of previous collaboration. This ﬁnding may indicate an accumulative advantage
associated with preferential attachment. We do not ﬁnd clear-cut association between
diﬀerences in the visibility of countries in the network, as another proxy for preferential
attachment and changes in the number of cross-country research collaboration. More-
over, homophily in terms of income groups and language similarities has no unambiguous
association with changes in the amount of collaboration. Multi-connectivity, in terms of
diﬀerent countries connecting two actors, is positively related to changes in the collabo-
ration intensity between countries, whereas we ﬁnd a negative association for the number
of shortest paths among countries.
The remainder of the paper is structured as follows: Section 2 presents related litera-
ture on research networks and its dynamics. In Section 3, we present the methods and
the data used in this paper. Descriptive network statistics and visualizations of selected
networks can be found in Section 4. Results of our regression analysis are presented in
Section 5. Finally, Section 6 concludes.
2
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2.1 Research Networks
A network in an economic sense is composed of heterogeneous actors, the relationships
among them and other contextual features that aﬀect actors’ behavior and decisions as
well as the generation and application of knowledge. Concerning the actors involved,
many network studies focus on the organizational rather than on the personal, regional,
or international level. Regardless which level of analysis is chosen, actors diﬀer from
each other in many respects. They have diﬀerent knowledge and competencies, diﬀerent
rules of action and diﬀerent incentives and motivations. They are linked to one another
through a web of diﬀerent relationships, including formal links, e.g. contractual coop-
eration agreements, as well as less formal relationships, such as joint membership in a
community of practice or a regional economy, and all kinds of ”intermediate relations”
(Powell and Grodal, 2005, McKelvey et al., 2004).
With respect to a more informal mode of relationships among actors, namely sci-
entiﬁc collaboration, there is a large body of evidence for an increasing amount of
co-authored research. This trend towards scientiﬁc collaboration has been found in a
broad set of disciplines and across diﬀerent periods (Wuchty et al., 2007, Wagner-D¨ obler,
2001, de Solla Price, 1963). These studies suggest that the interconnectedness of authors
and institutions has considerably increased during the last decades. The increase in
scientiﬁc collaboration is not restricted to the national level. Adams et al. (2005)
show, on a large sample of publications originating in U.S research universities, that
national and international collaboration increased from the 1980s to the late 1990s.
These results are in line with many other studies pointing out the increasing amount
of international scientiﬁc collaboration in Europe (e.g. Mattsson et al., 2008, Frenken,
2002, Okubo and Sj¨ oberg, 2000). Hence, co-publication networks reveal an expansion
in the number of involved countries and the connections among them. However, not all
countries are connected to the core, and some are grouped in otherwise disconnected
clusters. Over time, the global scientiﬁc network has become less centralized, with new
regional hubs emerging (Wagner and Leydesdorﬀ, 2005a).
3
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spect to R&D and innovative activities in general. Hagedoorn (2002) shows an increasing
number of R&D alliances since the 1980s. These alliances are geographically concen-
trated among North America, Europe, Japan, and South Korea. They can be found
in a diverse set of industries, such as the computer, semiconductor, chemical and
footwear industries (e.g. Boschma and ter Wal, 2007, Ahuja, 2000, Saxenian, 1991).
Moreover, collaborative R&D activities show an increasing level of internationalization
(Guellec and van Pottelsberghe de la Potterie, 2001, Granstrand, 1999).
In the pharmaceutical industry, the R&D process is based on a diverse set of
knowledge from diﬀerent scientiﬁc disciplines. The rapid growth of the knowledge base
and its dispersion among a broad variety of actors implies a pronounced trend towards
collaboration and network formation. Therefore, innovative activities have been organized
in a new organizational form as network of collaborative relations among a diverse set
of diﬀerent actors (Powell et al., 2005, McKelvey et al., 2004). The economic literature
presents diﬀerent interpretations of the motivation, nature, structure, and functions of
the observed networks. According to Gambardella (1995) and Arora and Gambardella
(1994), collaboration is a new form of organization in response to an increasingly codiﬁed
and abstract knowledge base. Other interpretations see the industry structure as a
transient phenomenon or stress that innovations are the outcome of interaction and
collaboration among actors with complementary resources and competencies (e.g. Pisano,
1991, Orsenigo, 1989).
On the organizational level, numerous studies have described and visualized the
growth of R&D partnerships between diﬀerent types of actors, including established
pharmaceutical companies, biotechnology ﬁrms, universities, public research institutes,
and venture capitalists (e.g. Roijakkers and Hagedoorn, 2006, Powell et al., 2005). Much
less emphasis has been put on the international dimension of collaboration networks.
On the country level, the network of international R&D projects based on patent
data reveals the central role of U.S. based organizations for connecting pharmaceutical
research originating in diﬀerent countries (Owen-Smith et al., 2002).
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particularly pronounced when biotechnological knowledge is involved and regionally
clustered actors extent their collaboration beyond national borders (Cooke, 2006). This
tendency is reinforced by the fact that biotechnology and pharmaceutical companies
locate R&D facilities outside their home countries, connect to a considerable number of
international research partners, and source knowledge on a global scale (Tijssen, 2009,
Gassmann and von Zedtwitz, 1999). Publication data reﬂects these observations. In
almost one quarter of corporate research publications, institutions from at least three
world regions are involved (Calero et al., 2007).
2.2 Network Dynamics
Based on the increasing importance of international scientiﬁc collaboration, we analyze
changes in collaboration networks over time. The notion of change in evolutionary
economics emphasizes processes that lead to a transformation of the economy and its
subsystems from within (Witt, 2008, Schumpeter, 1912). Thereby, future events are not
independent from past events and the sequence of events inﬂuences the outcome. In
the context of collaboration networks, this evolutionary view implies that the actors’
positions and the connections within the network inﬂuence future formation and break-up
of ties. Hence, the main question in the analysis of network dynamics is how the network
structure in previous periods aﬀects interactions among actors, speciﬁcally the formation
of ties within the network, in subsequent periods (Kenis and Knoke, 2002). There are
several theories that aim to explain the dynamics observed within networks over time.
In this paper, we concentrate on the concepts of preferential attachment, homophily, and
multi-connectivity in order to explain the development of cross-country collaboration
networks in pharmaceutical research.
Preferential Attachment
Real world networks are not randomly generated, but show a highly skewed distribution
of connections among the involved actors. A small number of actors shows a high
number of connections within the network, whereas the vast majority of actors has
relatively few connections. The distribution of the actor connectivity in real world
networks frequently follows, at least asymptotically, a scale-free power law (Barab´ asi,
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and already connected actors may build up new connections. The concept of preferential
attachment is used to explain the process of growth and intensiﬁed collaboration within
the network with the characteristics of the network itself. Following the concept of
preferential attachment, new and less well connected actors establish ties preferably to
well connected incumbents. Put diﬀerently, the concept states that highly connected
actors at one point in time are more likely to attract new connections in the future. Thus,
preferential attachment leads over time to a ”rich-get-richer” phenomenon in which early
entrants increase their connectivity at the expense of newcomers.
Empirical analyses suggest that the mechanism of preferential attachment provides
an explanation for the network structures observed in scientiﬁc co-authorship in diﬀerent
disciplines (Wagner and Leydesdorﬀ, 2005b, Jeong et al., 2003, Newman, 2001). Focusing
on the ﬁrm-level in the pharmaceutical industry after the emergence of biotechnology,
Orsenigo et al. (1998) show that the network of collaborative R&D agreements expands
but its structural properties remain rather stable. Particularly, the authors ﬁnd no
deformations of the core-periphery structure and a low propensity to collaborate among
ﬁrms of similar age. These results indicate that preferential attachment may have been
the driving force in the evolution of the network (Ter Wal and Boschma, 2009). On the
organizational level, Gay and Dousset (2005) ﬁnd evidence for preferential attachment
to central actors in the network of antibodies. In contrast to the theoretical arguments,
preferential attachment in their study seems not to be linked to the age of the actors,
but rather to the value of their core competencies.
Homophily
In most real world networks, the tendency to connect to highly connected actors is
not as high as theoretical models predict. One reason for this observation is that the
number of connections an actor can meaningfully maintain is limited. Furthermore,
partnering decisions may be inﬂuenced by multiple dimensions of proximity. Conse-
quently, actors may be attracted by those with the highest connectivity, but prefer to
connect to proximate actors (Boschma and Frenken, 2010). Persons and organizations
often build up their connections based on similar characteristics in a broad variety
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an overview see McPherson et al., 2001, Freeman, 1996). The theoretical concept of
homophily, stating that connections are established based on the similarity of the
actors involved, provides an explanation for the empirical observations. Tie formation
based on similarities within the network can be based on restricted opportunities to
connect to dissimilar actors induced by the group o which an actor belongs, and by
homophilous preferences (McPherson and Smith-Lovin, 1987). The underlying reasoning
of the homophily mechanism is that actors that share similar attributes are more likely
to develop characteristic-based trust and to participate in trust-based activities (cf.
Zucker, 1986). A high level of similarity among the actors of a network promotes mutual
understanding and thus, inﬂuences the frequency and intensity of communication and
interaction as well as the joint use of knowledge and other resources. Hence, interaction
within homogeneous networks is subject to a self-reinforcing process generated within
the network (Rogers, 1995). In order to proﬁt from the frequent interaction suggested by
homophily mechanism, networks expand by building up new ties to actors having similar
characteristics.
In the scientiﬁc domain, women have been found to collaborate more often with
other women, and researchers in general tend to connect preferably to people in their own
work group (Bozeman and Corley, 2004). Empirical evidence suggests that partnering
choices in science are not the only collaborative environments in which homophily may
play a role. Ruef et al. (2003) show that the composition of entrepreneurial founding
teams is strongly inﬂuenced by homophily based on achieved and ascribed characteristics.
In contrast to the individual level, evidence on the organizational level seems to be
less clear. In a study on inter-organizational alliances in German stock photography,
Gl¨ uckler (2010) ﬁnds that organizational homophily is a relatively weak explanation for
the formation of new strategic alliances. Moreover, his results suggest that dissimilarities
among the organization may also drive network formation. In the biotechnology industry,
however, alliance formation is related to homophily (Kim and Higgins, 2007).
Multi-connectivity
Network formation based on preferential attachment and homophily has been contrasted
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multiple connections among the actors of a network through both direct interaction
and intermediaries, driven by a preference for relational diversity (Powell et al., 2005).
Networks expand through the establishment of a broad set of independent linkages
among the actors. The process may be self-reinforcing, since actors who are more
diversely linked are more likely to attract more new connections over time than their less
diversiﬁed counterparts. Hence, a cohesive network structure can evolve.
Empirical evidence shows that the mechanism of multi-connectivity is best suited
to provide an explanation for the formation of strategic alliances in the German stock
photography market. The results suggest that two ﬁrms are more likely to engage in a
partnership if they are connected via third parties (Gl¨ uckler, 2010). Based on a sample
of alliances in life sciences between diﬀerent types of actors, Powell et al. (2005) ﬁnd
support for the multi-connectivity hypothesis. Their results indicate that the likelihood
of new alliances formation is higher among those actors who are more diversely connected
to each other in the previous period.
Based on the previous literature, we ﬁnd that diﬀerent mechanism can provide ex-
planations for the observed endogenous network dynamics in real world networks.
However, empirical studies show that diﬀerent mechanisms may be relevant at the same
time and that there is no clear-cut explanation, as to which mechanism may explain
the network dynamics in the network of cross-country collaboration in pharmaceuticals.
Therefore, we aim to analyze the relationship between three alternating mechanisms,
preferential attachment, homophily, and multi-connectivity, and the formation and
break-up of research collaboration at the country level.
3 Data and Research Methodology
3.1 Social Network Analysis
Social network analysis has been increasingly applied in economics to analyze inventor
and co-author networks (Cantner and Graf, 2006, Breschi and Catalini, 2010), knowledge
spillovers, and the development of technologies (Mina et al., 2007, Verspagen, 2007).
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patterns in diﬀerent subﬁelds of pharmaceutical research. The methodology has been
mainly developed by anthropologists, sociologists and researchers in social psychology, in
collaboration with mathematicians, statisticians, and computer scientists. The concept
of social networks is based on the assumption of the importance of relationships among
interacting units. Beyond this aspect, there are four additional paradigmatic properties
characterizing social network research. Behavior is seen as interdependent, relational
ties are means of resource transfer, the network structure provides opportunities and
constraints for individual actions, and the network structure illustrates lasting patterns
of relationships (Wasserman and Faust, 1994).
Following these basic characteristics, we can deﬁne a network as a ﬁnite set of ac-
tors and their relations among one another. Actors can be deﬁned as discrete individual,
corporate, or collective units (Wasserman and Faust, 1994). In the graphical representa-
tion of a network, actors are represented as nodes or vertices. Since we aim to analyze
cross-country collaboration in the pharmaceutical industry, we refer to countries as
actors in our network. Social ties represent linkages among actors. In order to establish
ties among countries, we use co-publications between diﬀerent organizations which may
or may not be located in diﬀerent countries. The collection of ties, i.e. co-publications,
deﬁnes the relations among the diﬀerent actors or countries. In the graphical represen-
tation of the co-publication network, relations among nodes are expressed by undirected
arcs.
In order to describe the properties of the cross-country collaboration networks in
diﬀerent therapeutic areas, we compute several descriptive statistics. The number of
actors describes the number of countries with at least one publication in the respective
ﬁeld. An important characteristic of a network graph is its connectedness, analyzed by
computing the number of components. It is connected if there is a path between every
pair of nodes. This implies that all pairs of nodes in the graph can be reached through
some path, regardless of its length. Nodes in a disconnected graph can be split up
into diﬀerent subgraphs, the so-called components, which are not connected among one
another. A component is a maximal connected subgraph (Wasserman and Faust, 1994).
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number of isolated, i.e. disconnected, nodes.
The density of a graph describes the general level of linkages among its nodes.
The density is deﬁned as the actual number of connections (edges) of a graph divided by




g (g − 1)
(1)
where g is the group size, i.e. the number of nodes in the graph, and d(ni) is the degree
of node i. The degree of a node represents its actual ties to other nodes. The density
can take values between 0 and 1. Since it is an average, one has to be careful with its
interpretation because the variation of the number of ties may be very high. The density
of a graph is inﬂuenced by the number of isolated nodes, since they have by deﬁnition a
degree of zero.
The mean nodal degree ¯ d reports the average degree, i.e. the average number of






We can transform the mean degree ¯ d into the density ∆ by dividing it with g − 1.
Actors can be deﬁned as central if they are involved in many relationships within
the network. We calculate diﬀerent centrality measures, indicating to what extend actors
show high or low levels of centrality and how heterogeneous actors’ centrality scores are
distributed. One of the simplest deﬁnitions of actor centrality states that central actors
have to be actively engaged in the network and thus possess a high number of linkages
to other actors. Following this idea, many researchers have used the degree of an node
as a centrality measure on the individual basis (see Freeman (1979) for an overview):
CD (ni) = d(ni) (3)
Since this measure depends on the group size, g, it has to be standardized in order to use
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with a high centrality level is among the most visible ones in the network, being directly
connected or adjacent to many others. Actors with low degrees are peripheral to the
network and thus less active in the relational process and the information ﬂows. In an
extreme case, an actor may be completely isolated.
Following Freeman (1979), we can use the measure of actors’ degree centrality to
construct a general index of graph centralization:
CD =
 g
i=1 [CD (n∗) − CD (ni)]
max
 g
i=1 [CD (n∗) − CD (ni)]
(5)
In the numerator, CD (ni) refers to the g actor degree indices and CD (n∗) to the largest
observed degree index. Degree centralization of a graph can be expressed by the observed
variation in the actor’s degree indices (numerator) divided by the maximum possible
variation (denominator). The denominator can be expressed directly by (g − 1)(g − 2)
(cf. Freeman, 1979), leading to:
CD =
 g
i=1 [CD (n∗) − CD (ni)]
[(g − 1)(g − 2)]
(6)
Equation 6 gives an index of the degree of centralization of the network’s set of actors.
Moreover, it can be interpreted as a measure of dispersion of the actor’s degree indices,
since the latter ones are compared to the maximum value. The degree centralization
index equals its maximum value of one if a single, central, actor is related to all other
g − 1 actors, who themselves only interact with the central actor. This is precisely the
situation we can ﬁnd in an ideal star graph. The minimum value of zero is attained if all
degrees are equal. This is the case in a regular graph that would correspond to a circle
graph (Wasserman and Faust, 1994).
Interactions between non-neighboring nodes are likely to depend on other actors,
particularly those lying on the path between the two. The latter ones may play a control
or intermediary role concerning the interactions between the other nodes, which can be
highly valuable for the entire network. The betweenness centrality of a node measures
the extent to which this node can be seen as a gatekeeper or broker in the network. This
idea has been used to construct the measure of betweenness centrality, which can be
considered as the probability that a path within the network takes a particular route.
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path is used. Freeman (1977) operationalised the idea as the actors’ betweenness index,








With i being distinct from j and k, let gjk (ni) denote the total number of shortest paths
linking actors j and k containing actor i. The probability that two actors, j and k, are
linked by an distinct actor i is given by gjk (ni)/gjk. The index CB (ni), which accounts
for i’s betweenness with respect to all actors j and k, can be standardized so that it





2 × CB (ni)
(g − 1)(g − 2)
(8)
The application of group betweenness centralization measures allows us to com-
pare diﬀerent networks with respect to the variation of the actors’ betweenness.





i=1 [CB (n∗) − CB (ni)]
 
(g − 1)
2 (g − 2)
  (9)
In the numerator, CB (ni) represents the actor betweenness index and CB (n∗) its largest
realization. The denominator is the numerator’s largest possible value. The index
reaches its maximum value of one in a star network, whereas the minimum value of zero
is reached if all actors have the same betweenness, i.e. in case of a line graph.
Within a network, a path can be characterized as a walk through the net where
all edges and all nodes are distinct. The length of a path is its number of edges. The
average path length is deﬁned as the average number of edges along the shortest paths
between all nodes of the network:
L =
1





where dij denotes the shortest path between the nodes i and j. The average path length
is a structural property of network graphs to determine whether a network ﬁts the small
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Another indicator that can be used to test the networks’ small world properties is
the clustering coeﬃcient or transitivity. The intuition behind this measure is the question
as to whether two actors connected to a third one interact among one another, too.
Accordingly, the clustering coeﬃcient measures the degree to which the nodes of the
network tend to cluster together, which can be interpreted as the cohesion of the network.
A triad involving the actors i, j and k is transitive if i is connected to j as well as j to
k and i to k (Wasserman and Faust, 1994). For the entire graph, we can compute the
global clustering coeﬃcient as the ratio of the number of triads N∆ and the number of





The clustering coeﬃcient can be interpreted as the probability that two neighbors of an
actor in the network are connected.
3.2 Network Regressions
In order to examine the endogenous mechanisms that drive dynamics of the cross-country
collaboration network in pharmaceuticals not only on an descriptive basis, we use mul-
tiple regression techniques for dyadic data (Butts and Carley, 2001, Krackhardt, 1988).
Following Krackhardt (1987), we can describe the relations within a network by a n × n
adjacency matrix Y :
Y =

     

0 y1,2 ... y1,n−1 y1,n
y2,1 0 ... y2,n−1 y2,n
. . .
. . . ... . . .
. . .
yn,1 yn,2 ... yn,n−1 0

     

(12)
The elements yi,j of the matrix Y equal zero if there is no relation between actor i and
actor j and are equal to any other value otherwise. Thus, the values of yi,j indicate the
strength of the relation between both actors. For the use in regression techniques, the
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y =








     

(13)
Applying this transformation to all variables leads to the generalized regression equation
for undirected relations (cf. Cantner and Graf, 2006):
yij = α + β
′xij + ǫij for all i < j (14)
Here, the dependent variable yij may refer to the amount of collaboration between i and
j or, as in our analytical framework, to the change in the amount of collaboration. x
is a matrix containing the explanatory variables related to the actor pair i and j. This
model can be estimated using standard OLS regression techniques. The coeﬃcients are
interpreted in the usual way.
Social network data require diﬀerent techniques to examine the coeﬃcients and
particularly their the signiﬁcance, since the assumptions of the standard OLS model
are usually violated, e.g. by structural autocorrelation, which frequently appears either
in rows or columns of the network matrix (Krackhardt, 1987). Thus, conventional test
statistics may provide misleading standard errors and signiﬁcance levels. The multiple
regression quadratic assignment procedure (MRQAP) has been found to be an appropri-
ate method to derive more correct inferences concerning the signiﬁcance of the model’s
coeﬃcients (Hubert, 1987). This procedure provides a general, permutation-based,
non-parametric test of the signiﬁcant relation of two structures (see among others
Hubert and Schultz, 1976, Mantel, 1967). The general idea of MRQAP is to generate the
reference distribution by random permutation of original data matrix’ rows and columns
against which the coeﬃcients are compared. All rows and columns of the matrix are
identically permuted, which ensures that the structure of the matrix remains unchanged,
except for those referring to the order of the objects within the matrix (Dekker et al.,
2007, Nagpaul, 2003).
The MRQAP procedure has been found to be quite robust against autocorrelation
14
Jena Economic Research Papers 2011 - 055encountered in network data. We use the double semi-partialing method (DSP) proposed
by Dekker et al. (2007, 2003), since it provides a version of the MRQAP procedure that
is robust against multicollinearity and other conditions such as skewness of the data.
MRQAP models require a relatively large number of random permutations. In our study,
we use 10,000 replications of this procedure, since this number allows for a suﬃcient
approximation of the reference distribution (cf. Jackson and Somers, 1989).
3.3 Data
Our empirical analysis is performed on a unique dataset of publications in scientiﬁc
journals related to pharmaceutical research. It was constructed by using diﬀerent data
sources in the following way: First, a list of 251 medical indications was drawn from the
BioPharmInsight database.1 Each indication represents a condition, disease or symptom,
which allows for the development of a particular procedure or treatment. Each indication
is exclusively assigned to one out of 15 therapeutic areas that correspond to a system of
an organism or a general disease group.2 Therefore, indications assigned to one and the
same therapeutic area are considered to be more related than indications that belong to
diﬀerent therapeutic areas.
The list of medical indications was used to conduct a keyword search in the Web
of Science databases (WoS). The WoS consist of seven databases containing infor-
mation gathered from an extensive number of journals, books, book series, reports
and conferences. Among these databases, the most important is the Science Citation
Index Expanded (SCI), a multidisciplinary index of more than 6,500 scientiﬁc journals,
covering 150 scientiﬁc disciplines. The SCI covers, among others, the scientiﬁc ﬁelds of
biochemistry, medicine and pharmacology which are of particular interest for our study.
The WoS includes information concerning the scientiﬁc publications themselves, such
as the title, the year of publication, the journal, cited references, a categorization of
the research ﬁelds, to which a publication can be assigned, and further bibliographic
information. In addition to this information, the WoS reports for most articles the
authors’ aﬃliations and their addresses including the country of origin. However, prior
1http://www.inﬁnata5.com/biopharm/
2Table 4 provides an overview of the therapeutic areas included in the dataset.
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Publications that contain at least one medical indication from our keyword list in
their title have been included in our dataset. In order to reﬁne the results, we only
take into account publications included in categories related to pharmaceutical research.
More precisely, articles assigned to the subcategories ”Biochemistry & Molecular Biol-
ogy”, ”Biotechnology and Applied Microbiology”, ”Chemistry, Applied”, ”Chemistry,
Medicinal”, ”Medicine, Research & Experimental”, ”Pharmacology & Pharmacy” and
”Toxicology” are included.3 We restrict our sample to journal articles and exclude
journal publications that are labelled as meeting abstracts, editorials or reviews, as well
as other non-journal publications. Conference proceedings have not been considered
either, since they might be of diﬀerent quality compared to published papers and may
be already included as published articles in the dataset. For the period from 1998 to
2008, we obtain 113,057 articles. We further restrict our sample to all articles that
contain information concerning the authors’ aﬃliations. In total, our sample consists
of the 111,096 journal articles. In order to analyze the development of cross-country
scientiﬁc collaboration over time, we distinguish three sub periods, 1998 to 2000, 2002
to 2004, and 2006 to 2008. We do not take the years 2001 and 2005 into account in
order to have periods of equal length and to have a clear separation among the sub periods.
We extract information concerning the authors’ aﬃliations and their countries of
origin and match it with World Bank income groups in order to have some information
concerning the wealth level of the countries in our sample. Articles in the categories
”Biochemistry & Molecular Biology” and ”Biotechnology and Applied Microbiology” are
regarded as biotechnology publications. The CHI classiﬁcation of journals (Hamilton,
2003) gives us the opportunity to classify each article according to the type of research
prevalent in the journal, in which it is published. The application of this classiﬁca-
tion scheme enables us to distinguish ”clinical observation”, ”clinical mix”, ”clinical
investigation”, and ”basic biomedical research” publications. We employ the CEPII
(Centre d’´ Etudes Prospectives et d’Information Internationales) database on distance
measures in order to get information concerning language similarities among countries
3The subcategories are described in detail at http://scientiﬁc.thomsonreuters.com/mjl/.
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Publication data provide the advantage of getting access to highly detailed infor-
mation included in scientiﬁc articles that are usually available for a long time span.
However, there are some drawbacks that have to be taken into account when analyzing
co-publication data. The most important are that research does not necessarily lead to
publication, co-authorship may only partly capture scientiﬁc collaboration, the impact of
publications diﬀers considerably and publication habits diﬀer among scientiﬁc disciplines.
Publication databases may be biased towards English language publications and journals
published in industrialized countries. Although researchers using co-publication data
face the mentioned shortcomings, this type of data has been found to be an appropriate
indicator for scientiﬁc collaboration if large datasets, concentrated in one scientiﬁc ﬁeld
and aggregated on the country level, are used (see e.g. Katz and Martin (1997), Laudel
(2002), Lundberg et al. (2006), and Hoekman et al. (2009) for a discussion).
4 International Research Networks
4.1 Network Descriptives and Visualizations
In this section, we employ social network analysis to visualize diﬀerences in the cross-
country collaboration patterns in pharmaceutical research in various therapeutic areas.
Cross-country collaboration networks on the country level are illustrated with Pajek (see
de Nooy et al., 2005) applying the algorithm proposed by Fruchterman and Reingold
(1991). Furthermore, we use the igraph package by Garbor Csardi and netmodels package
by Domingo Vargas for R statistical software to calculate descriptive network statistics.
The spatial position of individual countries within the network represent their relative
centrality.
We start our analysis taking into account all journal publications in the respective
therapeutic areas and periods. The descriptive network statistics presented in Table 1 re-
veal some general trends in the development of cross-country networks of pharmaceutical
research. The number of countries participating in the cross-country research community
and the relative size of the largest component, i.e. the largest group of connected
17
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corresponds to a decrease in the share of isolated countries, which do not collaborate
with other countries. However, their absolute number increases in eight therapeutic areas.
Most networks show an increase in their density from the ﬁrst to the third period,
which indicates that the number of realized linkages grows faster than the number of
countries. However, the density remains quite close to its minimum value of 0 in all
subnetworks. In most networks, the increasing trend is not stable, i.e. that the density
decreases in at least one period. The highest share of realized compared to possible
linkages, 14.1%, is reached in the area of central nervous system research in the ﬁrst
period. The lowest value with 2.4% is observed in dermatology in the same period. With
a few exceptions, the mean number of other nations to which a country is connected
is increasing from the ﬁrst to the third period. We interpret this as a hint that the


















































































































































































































































All 1 136 7 130 0.956 6 0.044 0.107 14.397 0.576 0.221 2.070 0.427
All 2 141 9 133 0.943 8 0.057 0.119 16.723 0.582 0.195 2.045 0.487
All 3 154 1 154 1.000 0 0.000 0.136 20.779 0.597 0.167 2.068 0.499
1 1 73 11 63 0.863 10 0.137 0.109 7.863 0.530 0.244 2.091 0.449
1 2 84 9 76 0.905 8 0.095 0.120 9.929 0.556 0.221 2.098 0.483
1 3 101 7 95 0.941 6 0.059 0.127 12.673 0.554 0.212 2.092 0.492
2 1 73 15 58 0.795 13 0.178 0.091 6.548 0.449 0.166 2.184 0.443
2 2 84 15 70 0.833 14 0.167 0.082 6.786 0.422 0.157 2.309 0.443
2 3 89 15 75 0.843 14 0.157 0.118 10.382 0.402 0.122 2.226 0.535
3 1 56 7 50 0.893 6 0.107 0.141 7.750 0.495 0.259 2.024 0.512
3 2 68 9 60 0.882 8 0.118 0.123 8.235 0.596 0.286 2.023 0.453
3 3 79 10 70 0.886 9 0.114 0.127 9.899 0.527 0.207 2.082 0.500
4 1 31 20 5 0.161 16 0.516 0.024 0.710 0.117 0.013 1.565 0.000
4 2 32 17 16 0.500 16 0.500 0.054 1.688 0.183 0.113 2.358 0.510
4 3 35 18 18 0.514 17 0.486 0.049 1.657 0.260 0.153 2.418 0.351
6 1 48 16 33 0.688 15 0.313 0.058 2.708 0.406 0.242 2.388 0.297
6 2 54 12 43 0.796 11 0.204 0.084 4.444 0.481 0.307 2.174 0.353
Continued on next page
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6 3 69 16 53 0.768 14 0.203 0.067 4.580 0.491 0.254 2.146 0.337
7 1 67 16 51 0.761 14 0.209 0.071 4.687 0.364 0.200 2.460 0.451
7 2 68 14 55 0.809 13 0.191 0.083 5.559 0.499 0.242 2.221 0.432
7 3 77 14 64 0.831 13 0.169 0.096 7.325 0.482 0.175 2.185 0.430
8 1 42 14 29 0.690 13 0.310 0.057 2.333 0.401 0.326 2.495 0.282
8 2 44 14 30 0.682 12 0.273 0.056 2.409 0.429 0.319 2.326 0.274
8 3 55 12 44 0.800 11 0.200 0.071 3.855 0.464 0.337 2.314 0.347
9 1 59 14 44 0.746 12 0.203 0.061 3.525 0.276 0.190 2.526 0.383
9 2 55 14 41 0.745 12 0.218 0.065 3.491 0.433 0.265 2.352 0.305
9 3 63 14 50 0.794 13 0.206 0.084 5.206 0.513 0.345 2.287 0.528
10 1 24 11 14 0.583 10 0.417 0.098 2.250 0.415 0.168 1.824 0.425
10 2 28 11 18 0.643 10 0.357 0.074 2.000 0.439 0.271 2.078 0.250
10 3 38 14 25 0.658 13 0.342 0.077 2.842 0.318 0.165 2.307 0.414
11 1 59 15 44 0.746 13 0.220 0.063 3.627 0.399 0.261 2.317 0.314
11 2 64 12 53 0.828 11 0.172 0.082 5.156 0.473 0.315 2.294 0.384
11 3 72 12 61 0.847 11 0.153 0.129 9.194 0.446 0.154 2.086 0.515
12 1 58 8 50 0.862 6 0.103 0.084 4.793 0.603 0.419 2.151 0.282
12 2 56 11 45 0.804 9 0.161 0.110 6.071 0.489 0.262 2.053 0.475
12 3 72 12 61 0.847 11 0.153 0.103 7.306 0.474 0.197 2.168 0.484
13 1 116 13 104 0.897 12 0.103 0.080 9.224 0.458 0.186 2.189 0.359
13 2 121 7 115 0.950 6 0.050 0.109 13.091 0.508 0.206 2.154 0.467
13 3 132 4 129 0.977 3 0.023 0.111 14.576 0.585 0.188 2.104 0.399
15 1 50 15 34 0.680 12 0.240 0.080 3.920 0.384 0.152 2.062 0.352
15 2 52 11 42 0.808 10 0.192 0.102 5.192 0.465 0.194 2.156 0.399
15 3 65 16 50 0.769 15 0.231 0.072 4.585 0.474 0.253 2.274 0.385
16 1 45 12 27 0.600 8 0.178 0.084 3.689 0.293 0.109 2.000 0.433
16 2 44 13 31 0.705 11 0.250 0.122 5.227 0.360 0.159 2.026 0.505
16 3 54 15 39 0.722 13 0.241 0.091 4.815 0.376 0.181 2.082 0.423
17 1 67 7 61 0.910 6 0.090 0.112 7.373 0.447 0.308 2.268 0.465
17 2 62 11 52 0.839 10 0.161 0.106 6.484 0.483 0.203 2.127 0.436
17 3 77 10 68 0.883 9 0.117 0.095 7.195 0.484 0.211 2.277 0.403
Table 1: Network Descriptive Statistics
The degree centralization measure equals values above 0.4 in most networks over all
three periods, indicating that the number of linkages is quite dispersed among countries
19
Jena Economic Research Papers 2011 - 055in the majority of the analyzed networks. This ﬁnding indicates that some countries
collaborate more than others. All betweenness centralization measures are below 0.42,
which indicates some dispersion of this measures among the actors in all subnetworks.
Table 1 shows that the average path length between countries is rather stable, above 2 in
most therapeutic areas. In 10 therapeutic areas, the clustering coeﬃcient as a measure
for coherence of the network increases, from the ﬁrst to the third period, which can be
seen as another indicator of increasing cross-country collaboration.
For illustration of the diﬀerences among therapeutic areas, we choose the cross-
country collaboration networks in cancer (Therapeutic Area 1), infectious diseases (13)
and dermatology research (4). In the case of cancer, the network shows a relatively high
density and connectedness. For our ﬁrst period of analysis, from 1998 to 2000, cancer
publications originated in 73 countries: this number increases to 84 and 101 for the years
2002 to 2004 and 2006 to 2008, respectively. The size of the largest component increases
from 86.93% of the countries in the ﬁrst to 94.1% in the third period. This increase is
accompanied by a decrease in the absolute and relative number of isolated countries. The
density of the network increases over time from 0.109 in the ﬁrst to 0.127 in the third
period, indicating an increasing interconnectedness of the countries in the network. Over
time, each country in the network is on average connected to more countries. The mean
degree rises from 7.863 in the ﬁrst to 12.673 in the third period. Nevertheless, the degree
centralization measure is above 0.5 in all sub-periods, indicating that some countries
have a considerably higher number of connections than others . The decrease of the
betweenness centralization measure form 0.244 to 0.212 reveals a decreasing variation of
the actors betweenness indices. The average path length stays relatively constant around,
2.09, whereas the increase of the clustering coeﬃcient from 0.449 to 0.492 indicates that
the network becomes more coherent over time.
Figure 1 illustrates the increasing connectedness of countries in the cancer research
network. By visual inspection, we see that the most central actors in all three periods
can be found among high income OECD member states. Among these are countries that
have a rather strong pharmaceutical industry. Particularly, these countries are located
in the center of the network. Most upper middle income and non-OECD high income
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that China managed to become a central actor in the cancer research network. Several
other newly industrializing countries are close to the center of the network, e.g. Brazil,
India and Oman. However, most lower middle income and low income countries remain
in peripheral positions.
Similar to the cancer network, the cross-country research network in infectious
diseases shows a relatively high level of participation and connectedness. The number of
actors rises from 116 in the ﬁrst and 121 in the second to 132 in the third period. This
development is accompanied by an increase in the relative size of the largest component,
from 89.7% to 97.7%. Hence, the absolute and relative number of isolated countries
decreases over time. The density of the network increases from 0.08 to 0.111, indicating
that more possible linkages among the countries are realized. The average number of
connections a country has build up rises from 9.224 connections in the ﬁrst period to
14.576 in the third period. The dispersion of actors’ degree indices, expressed by the
degree centralization, increases over time from 0.458 to 0.585, whereas the dispersion of
countries’ betweenness indices stays rather constant at around 0.2. The average path
length decreases slightly. Network cohesion, as indicated by the clustering coeﬃcient,
increases slightly from the ﬁrst to the third period. However, the cohesion is highest in
the second period.
Visual inspection of the infectious diseases networks in Figure 2 reveals a pattern
quite similar to the one in the cancer network. The core of the network is dominated
in all three periods by high income OECD countries. Lower and upper middle income
countries are mainly located around the core, but are connected to it. However, many of
these countries seem to be connected through multiple paths to the core of the network.
In the ﬁrst period, Brazil and Thailand have prominent positions within the center of
the network, but they become more peripheral actors in the subsequent periods. In
the second period, we observe a cluster of Eastern European and former Soviet Union
member states that is connected to other participants of the network, but indicates
intense collaboration among these countries. In the third period, however, this cohesive
group can no longer be identiﬁed. In contrast to the cancer network, more lower middle
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(b) 2002-2004
(c) 2006-2008
Figure 1: Cross-Country Research Networks in Cancer (Therap. Area 1)
Income Groups: high income non-OECD (pink), high income OECD (yellow),
low income (white), lower middle income (green),
upper middle income (red), not classiﬁed (orange)
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on, which might be associated with the prevalence of infectious diseases in these countries.
In the visualization of cross-country collaboration in dermatology in Figure 3, we
see that the number of countries engaged in this therapeutic area is considerably lower
compared to cancer and infectious diseases. The number of actors in the network rises
from 31 in the ﬁrst to 35 in the third period, but collaboration among the countries in
the graph seems to be not very intense. We ﬁnd a consistently large number of diﬀerent
components, most of them consisting of isolated countries. Around 50% of all countries
are not connected to any other nation in the network. Hence, we ﬁnd relatively low
values for the density and the mean degree, although connectedness rises over time. The
degree centralization rises over time as the network becomes more connected, indicating
that some actors build up more ties than others. The same applies to the betweenness
centralization. The average path length and the clustering coeﬃcient increase over time.
However, the network remains relatively unconnected in all three periods.
Most of the countries active in the ﬁeld of dermatology are, again, high income
OECD countries. These countries account for the vast majority of connected actors in
the three periods of observations. There are few upper and lower middle income countries
that are connected to other nations in one of the three periods. Moreover, we do not ﬁnd
published research originating in low income countries in this ﬁeld.
In further steps, we restricted our analysis to basic research and biotechnology
publications in order to examine whether the trend towards increasing collaboration
described earlier can be found in this subﬁeld as well. The number of countries involved
in these types of research is, in general, somewhat lower compared to the complete
networks. Nevertheless, the number of involved countries increases over time in most
networks and the countries increase collaboration among one another. As in the case of
the complete networks, high income OECD countries can be found in the center whereas
developing and newly industrializing countries can be found in peripheral positions of
the network. Consequently, the cross-country research network in the ﬁelds of basic and
biotechnology research show similar patterns as the networks, including all journal articles
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(b) 2002-2004
(c) 2006-2008
Figure 2: Cross-Country Research Networks in Infectious Diseases (Therap. Area 13)
Income Groups: high income non-OECD (pink), high income OECD (yellow),
low income (white), lower middle income (green),
upper middle income (red), not classiﬁed (orange)
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(b) 2002-2004
(c) 2006-2008
Figure 3: Cross-Country Research Networks in Dermatology (Therap. Area 4)
Income Groups: high income non-OECD (pink), high income OECD (yellow),
low income (white), lower middle income (green),
upper middle income (red), not classiﬁed (orange)
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collaboration is not driven by an expanding number of journals, we restrict our sample
to those journals that have been included in the WoS prior to 1998 according to the
CHI classiﬁcation. The results for this subsample are in line with the original analysis.
The analysis of weighted instead of binary networks reveals a trend towards increasing
collaboration and cohesion. The mean degree, the average collaboration intensity, and
the clustering coeﬃcient are increasing over time in all therapeutic areas. Again, high
income OECD countries can be found in central positions within the networks.
4.2 Entry and Exit
In the previous section, network statistics and visualizations, seem to indicate intensiﬁed
collaboration across countries in almost all therapeutic areas. We ﬁnd that an increas-
ing number of countries are engaged in collaborative pharmaceutical research across
borders. However, the network visualizations already indicate that not all countries are
persistently engaged in cross-country research projects. In this section, we analyze the
number of entries, exits and persistently contributing countries in more detail. In doing
so, we calculate the mean degree, i.e. the average number of connections an actor has,
for the three subgroups mentioned. The connectivity of actors within the network may
be associated with their research performance and their decision to leave the network.
Based on evidence on the individual and organizational level, we expect countries to
leave the network because of a weak position therein, i.e. a relatively low number of
connections to other actors (cf. Cantner and Graf, 2006, Powell et al., 1999).
Table 2 reveals a considerable number of entries and exits from the ﬁrst to the
second and from the second to the third period in all therapeutic areas. In 13 out of 15
therapeutic areas, at least ten countries enter, and in six therapeutic areas, the number of
exits is at least ten in the period 2002 to 2004. The number of entering countries exceeds
the number of exits in eleven therapeutic areas. In the third period, we ﬁnd positive
net entry and more than ten entering countries in all therapeutic areas. However, the
number of exits increased in six therapeutic areas compared to the previous period. The
positive net entry in most therapeutic areas, particularly in the third period, suggests,
again, that scientiﬁc collaboration in pharmaceuticals has become more international.
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and break-up of ties within the networks.
With respect to the mean degree of each subgroup, entering, exiting and perma-
nent actors, we ﬁnd considerable diﬀerences in all therapeutic areas among these groups.
Permanent actors are connected to a by far higher number of other countries than
entering and exiting countries. This ﬁnding is prevalent for entries and exits from
the ﬁrst to the second and from the second to the third period. With respect to the
exiting countries, we interpret this as a hint that these countries left the cross-country
research network because of a relatively weak position in the respective ﬁeld in terms of
international contacts. For countries entering in the third period, we ﬁnd, on average,
a higher number of connections than for exiting countries. Nevertheless, entering
countries are far less connected than the permanent actors. The latter increase their
average number of collaborative ties in 13 out of 15 therapeutic areas. This ﬁnding
indicates that these countries increasingly engage in cross-country research collaboration.
The networks taking only basic research, biotechnology and articles included in
journals included in the WoS prior to 1998 show very similar patterns of entry and exit.
Again, the number of entries and exits is considerable and exiting countries are far less
connected than permanent actors.
5 Empirical Results Network Regressions
5.1 Variables
We present here an overview of the variables and controls used in our network regression
models in Table 5. The dependent variable is the change in the number of total
collaboration between two countries between period t−1 and period t. More precisely, we
calculate the amount of collaboration for each pair of countries in period t and subtract
the amount of collaboration in period t−1. The number of co-publications between each
pair of countries is calculated based on author aﬃliations. We use full counting, which
leads to a co-publication count of one for each pair of countries involved in a publication.
Since co-publications represent undirected links, each pair of countries is included only
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All 20 2.400 15 1.444 121 19.091 22 2.273 9 1.444 132 23.864
1 20 1.100 9 1.222 64 12.688 26 3.000 9 1.222 75 16.027
2 18 1.056 7 0.909 66 8.348 16 1.375 11 0.909 73 12.356
3 20 2.200 8 1.727 48 10.750 22 3.455 11 1.727 57 12.386
4 7 0.143 6 0.286 25 2.120 10 0.300 7 0.286 25 2.200
6 14 1.357 8 2.222 40 5.525 24 0.958 9 2.222 45 6.511
7 15 1.267 14 1.600 53 6.774 19 2.053 10 1.600 58 9.052
8 11 0.273 9 0.200 33 3.121 16 1.063 5 0.200 39 5.000
9 14 0.714 18 1.091 41 4.439 19 0.947 11 1.091 44 7.045
10 10 1.200 6 0.875 18 2.444 18 1.111 8 0.875 20 4.400
11 13 1.692 8 1.444 51 6.039 17 2.765 9 1.444 55 11.182
12 10 1.000 12 0.429 46 7.174 23 2.348 7 0.429 49 9.633
13 15 4.800 10 3.778 106 14.264 20 1.600 9 3.778 112 16.893
15 12 1.583 10 2.667 40 6.275 19 1.158 6 2.667 46 6.000
16 8 0.500 9 0.333 36 6.278 13 1.000 3 0.333 41 6.024
17 14 0.857 19 1.222 48 8.125 24 2.708 9 1.222 53 9.226
Table 2: Entries, Exits and Permanent Actors
once in a speciﬁc period and therapeutic area.
With respect to the independent variables, we draw upon multiple measures in or-
der to test the diﬀerent mechanisms of endogenous network dynamics presented in
Section 2.2. Following Gl¨ uckler (2010), we use absolute diﬀerences in countries’ degree
centrality scores lagged by one period as a proxy for preferential attachment (DegreeCen-
trality). This measure refers to diﬀerences in the visibility of countries in the research
network. The number of prior ties has been used as another indicator for an accumulative
advantage based on preferential attachment (cf. Powell et al., 2005). Therefore, we
include in our analysis the number of previous collaboration among two countries lagged
by one period (Collaboration).
28
Jena Economic Research Papers 2011 - 055Homophily is reﬂected by the variable IncomeSimilarity indicating whether the
two collaborating countries belong to the same World Bank income group, i.e. they
have comparable wealth levels. Moreover, we use language similarities among countries
as a proxy for homophily. More precisely, LanguageSimilarity equals 1 if at least 9%
of the population speak the same language. Multi-connectivity is captured by the
point connectivity for each country pair lagged by one period (PointConnectivity).
This measure indicates the number of other countries that have to be removed from
the network in order to disconnect two collaborating countries. Moreover, we use the
number of shortest paths between two countries in the network with a lag of one period
(GeodesicCount) as a further proxy for multi-connectivity (cf. Gl¨ uckler, 2010).
5.2 Regression Results
In Table 3, we present the results of our regression analysis on an aggregated level, i.e. we
do not distinguish among the diﬀerent therapeutic areas. Moreover, we concentrate on
actors that are members of the network in period t − 1 and t since most of our variables
are lagged by one period. This analysis may deliver some insight into which mechanisms
drive the formation and the break-up of ties within the network.4 Network correlations
of the independent variables can be found in Table 6 and 7.
With respect to preferential attachment as a driver of tie formation, we ﬁnd a
positive and signiﬁcant coeﬃcient for DegreeCentrality only in period 2. For this period,
this indicates a positive relation between diﬀerences in the degree centrality of actors
lagged by one period and changes in the intensity of collaboration. Since the respective
coeﬃcient is not signiﬁcant in the third period, we do not ﬁnd robust support for
tie formation and break up proxied by diﬀerences in countries’ visibility within the
network, as the mechanism of preferential attachment would suggest. Our results for
Collaboration show a positive and signiﬁcant association between previous collaboration
4Ideally, tie formation of entering countries would give some insights concerning the mechanisms
driving the dynamics of the network. However, the problem with this approach is that lagged variables for
entrants are not available, which makes it hard to identify the mechanisms at work with more sophisticated
methods. Therefore, we concentrate on tie formation and break up among permanent actors for which
lagged variables are available.
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result can be interpreted as a hint that previous collaboration can lead to an accumu-
lative advantage as often associated with the mechanism of preferential attachment.
Put diﬀerently, a joint collaboration experience may lead to a self reinforcing process
of intensiﬁed collaboration in which well connected actors form new ties among each other.
Homophily in terms of countries being in the same income group (IncomeSimilar-
ity) is not signiﬁcantly related to the formation and break-up of research collaboration.
Hence, our results do not suggest that either homophily or heterophily in terms of
income groups is associated with changes in the amount of collaboration. With respect
to language similarities (LanguageSimilarity), we ﬁnd a weakly signiﬁcant negative
relationship of the same language spoken in two countries and tie formation and break-up
in period 2. However, in period 3, we ﬁnd a weakly signiﬁcant positive association.
Consequently, our results do not suggest that homophily in terms of language similarities
among countries has a robust, clear-cut relationship to changes in the amount of
collaboration at the country-level.
We analyze whether multi-connectivity is suitable to explain changes in the amount of
research collaboration on the country level and ﬁnd a positive and signiﬁcant coeﬃcient
for PointConnectivity. This ﬁnding suggests that changes in the intensity of collaboration
are positively related to the number of countries that indirectly connect two actors.
Put diﬀerently, the intensity of collaboration may change due to knowledge ﬂows the
partners receive through other collaboration. The coeﬃcient for GeodesicCount, i.e. the
number of shortest paths, has a signiﬁcantly negative sign in both periods. The sign of
the coeﬃcient is rather intuitive, since a high number of shortest paths indicates that
there has been no direct interaction among two countries. Hence, our results suggest
that multiple shortest paths as a proxy for multi-connectivity are negatively associated
with tie formation and break up in both periods. Our results stay qualitatively similar if
we restrict our sample to collaboration in the ﬁelds of basic and biotechnology research,
as well as to those journals included in the WoS prior to 1998.
5Collaboration is the main source of diﬀerences in the adjusted R-squared, since it contributes much
less to this measure in period 2 compared to period 3.
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Estimate Pr(≥ |b|) Estimate Pr(≥ |b|)
Dependent Variable: ∆Collaboration
DegreeCentrality 5.3585 0.0127 2.3331 0.1273
Collaboration 0.2066 0.0000 0.6050 0.0000
IncomeSimilarity 0.9575 0.1141 -0.6612 0.2279
LanguageSimilarity -1.2698 0.0955 1.1834 0.0923
PointConnectivity 0.3179 0.0000 0.1841 0.0000
GeodesicCount -0.2228 0.0032 -0.0665 0.0678
Intercept -0.5978 0.1333 -0.3934 0.2237
Residual standard error 13.17 15.37
F-statistic (p-value) 323.5 0.0000 1672 0.0000
Adjusted R-squared 0.2279 0.5641
Nullhypothesis: MRQAP with DSP and 10,000 permutations
Table 3: Network Regression
6 Conclusion
Literature suggests that knowledge production and scientiﬁc research are increasingly
conducted in collaborative work between diﬀerent authors and institutions. Moreover,
collaboration becomes increasingly more international, particularly in the pharmaceutical
industry. In this study, we analyzed pharmaceutical research collaboration networks at
the country level in diﬀerent therapeutic areas. Our empirical analysis is based on a
unique dataset of journal publications related to pharmaceutical research. By means of
social network analysis, we ﬁnd that the cross-country research networks expand over
time in almost all therapeutic areas. More speciﬁcally, the number of countries involved
and their connectivity increases in most therapeutic areas. Visual inspection of the
networks reveals that high income OECD countries are located in the core of all networks.
This pattern remains rather stable over time and only few non-OECD countries manage
to become part of the center of cross-country pharmaceutical research networks.
In order to assess which mechanisms suggested by the literature, namely prefer-
ential attachment, homophily, or multi-connectivity, drive the endogenous network
dynamics, we employ multiple regression analysis for dyadic data. More precisely, we use
the MRQAP procedure with double semi-partialing permutation. Our regression results
reveal a positive association between the amount of previous research collaboration
and the change in the amount of collaboration, indicating an accumulative advantage
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countries’ degree centrality as another proxy for preferential attachment show no robust
signiﬁcant relation to changes in the collaboration intensity. Our results do not allow for
a clear-cut conclusion whether homophily or heterophily in terms of income groups and
language similarities is a driving mechanism in the change in cross-country collaboration.
Multi-connectivity in terms of diﬀerent countries connecting two actors is positively
related,whereas the number of shortest path shows a negative association with changes
in the amount of collaboration.
Our empirical results are in accordance with literature suggesting the growing amount
of collaborative work on the national and international level (e.g. Mattsson et al., 2008,
Adams et al., 2005). Network visualizations, measures of the network structures, and
the number of entries and exits reveal that the networks are changing over time. There
has been no clear consensus in the literature concerning the mechanisms driving the
evolution of diﬀerent networks. There has been evidence for preferential attachment
(e.g. Gay and Dousset, 2005), homophily (e.g. Gl¨ uckler, 2010), and multi-connectivity
(e.g. Powell et al., 2005) being the mechanism of tie formation in diﬀerent real world
networks. Our regression results indicate that the diﬀerent mechanisms analyzed may
inﬂuence to a diﬀerent extent the formation and break-up of ties at the same time.
However, for some of these measures, the coeﬃcients change their sign so that we cannot
draw unambiguous conclusions concerning their relation to changes in the collaboration
intensity. Moreover, the contribution to the adjusted R-squared diﬀers considerably
among the diﬀerent variables, with collaboration lagged by one period contributing the
most in both periods.
Since our investigation is restricted to pharmaceuticals, future research may focus
on the development of cross-country research collaboration in diﬀerent industries.
The pharmaceutical industry may provide an exceptional case due its pronounced
scientiﬁc foundation and networked industry structure. Moreover, the dataset used in
this study does not allow us to take policy interventions to stimulate cross-country
research collaboration into account. The respective programs may, however, inﬂuence
the intensity of cross-country research collaboration among countries. The size of a
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disease group, may also inﬂuence the number of cross-country collaboration. However,
the respective information is not available in our dataset. Cross-country collaboration is
built up by scientists working in diﬀerent types of institutions. Therefore, the analysis
of cross-country research collaboration on more disaggregated levels may deliver further
insights, into the way in which research collaboration is established and develops over
time.
33
Jena Economic Research Papers 2011 - 055A Appendix
A.1 List of Therapeutic Areas and Description of Variables
Therapeutic Area Therapeutic Area ID
Cancer 1
Cardiovascular 2
Central Nervous System 3
Dermatology 4











Table 4: List of Therapeutic Areas
Dependent Variable
∆Collaboration change in the number of collaboration among countries from
period t-1 to t
Independent Variables
DegreeCentrality Preferential Attachment diﬀerence in countries degree centrality lagged by one period
Collaboration Preferential Attachment amount of collaboration among two countries lagged by one
period
IncomeSimilarity Homophily dummy indicating whether 2 countries belong to the same
income group
LanguageSimilarity Homophily dummy indicating if at least 9% of the population in both
countries speak the same langugage
PointConnectivity Multi-connectivity number of other countries that have to be removed in order
to disconnect two actors lagged by one period
GeodesicCount Multi-connectivity number of shortest paths between two countries lagged by one
period
Table 5: Overview of Variables
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IncomeSimilarity 0.1053 0.1485 1
LanguageSimilarity 0.2025 0.0779 0.1147 1
PointConnectivity 0.3391 0.3479 0.3127 0.1513 1
GeodesicCount 0.2046 -0.0138 0.1560 0.0753 0.3801 1
































































































IncomeSimilarity 0.0715 0.1507 1
LanguageSimilarity 0.1719 0.0579 0.1217 1
PointConnectivity 0.2731 0.3421 0.3123 0.0750 1
GeodesicCount 0.2149 -0.0152 0.1530 0.0526 0.3140 1
Table 7: Network Correlations Period 3
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